These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polymorphism of the proto-oncogene ETS-1 in hematological malignancies. Kerckaert JP; Duterque-Coquillaud M; Collyn-d'Hooghe M; Morel P; Majérus MA; Laï JL; Fenaux P; Bauters F; Debuire B; Loucheux-Lefebvre MH Leukemia; 1990 Jan; 4(1):16-9. PubMed ID: 1967322 [TBL] [Abstract][Full Text] [Related]
3. Elevated frequency of an ETS-1 restriction fragment polymorphism in chronic B-cell leukaemia. Crossen PE; Morrison MJ Hum Genet; 1993 May; 91(4):380-2. PubMed ID: 8099060 [TBL] [Abstract][Full Text] [Related]
4. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines. Dreyfus F; Picard F; Gisselbrecht S; Varet B; Tambourin PE; Fichelson S Nouv Rev Fr Hematol (1978); 1989; 31(3):217-21. PubMed ID: 2694094 [TBL] [Abstract][Full Text] [Related]
5. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated. Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127 [TBL] [Abstract][Full Text] [Related]
6. Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23. Savage PD; Hanson CA; Kersey JH Blood; 1987 Jul; 70(1):327-9. PubMed ID: 2885050 [TBL] [Abstract][Full Text] [Related]
7. Restriction fragment length polymorphisms in the ETS-1 proto-oncogene. Comparison of Saudi and Western populations. Parkar MH; Seid JM; Rowson JM; Stringer BM; Vencer LJ; Aur RJ; Goyns MH Experientia; 1988 Dec; 44(11-12):1019-20. PubMed ID: 2461869 [TBL] [Abstract][Full Text] [Related]
8. BCL3 translocation in CLL with typical phenotype: assessment of frequency, association with cytogenetic subgroups, and prognostic significance. Rossi D; Deambrogi C; Monti S; Cresta S; De Paoli L; Fangazio M; Giardini I; Bernasconi P; Gaidano G Br J Haematol; 2010 Sep; 150(6):702-4. PubMed ID: 20553272 [No Abstract] [Full Text] [Related]
9. Sst I RFLP linked to the human ets-1 gene. Kerckaert JP; Dozier C; Loucheux-Lefebvre MH; Stehelin D Nucleic Acids Res; 1987 Jul; 15(14):5905. PubMed ID: 2886980 [No Abstract] [Full Text] [Related]
10. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639 [TBL] [Abstract][Full Text] [Related]
11. Structural and functional analysis of the regulatory sequences of the ets-1 gene. Oka T; Rairkar A; Chen JH Oncogene; 1991 Nov; 6(11):2077-83. PubMed ID: 1945412 [TBL] [Abstract][Full Text] [Related]
13. Novel restriction fragment length polymorphisms in the cellular oncogene SEA. Koduru PR; Goh JC; Broome JD Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480 [TBL] [Abstract][Full Text] [Related]
14. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases. Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654 [TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population. Hussain SR; Naqvi H; Raza ST; Ahmed F; Babu SG; Kumar A; Zaidi ZH; Mahdi F Cancer Epidemiol; 2012 Aug; 36(4):e227-31. PubMed ID: 22441130 [TBL] [Abstract][Full Text] [Related]
16. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. Pasqualucci L; Neri A; Baldini L; Dalla-Favera R; Migliazza A Cancer Res; 2000 Oct; 60(20):5644-8. PubMed ID: 11059755 [TBL] [Abstract][Full Text] [Related]
17. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693 [TBL] [Abstract][Full Text] [Related]
18. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Bories JC; Willerford DM; Grévin D; Davidson L; Camus A; Martin P; Stéhelin D; Alt FW Nature; 1995 Oct; 377(6550):635-8. PubMed ID: 7566176 [TBL] [Abstract][Full Text] [Related]